skip to main content
Visitante
Meu Espaço
Minha Conta
Sair
Identificação
This feature requires javascript
Tags
Revistas Eletrônicas (eJournals)
Livros Eletrônicos (eBooks)
Bases de Dados
Bibliotecas USP
Ajuda
Ajuda
Idioma:
Inglês
Espanhol
Português
This feature required javascript
This feature requires javascript
Primo Search
Busca Geral
Busca Geral
Acervo Físico
Acervo Físico
Produção Intelectual da USP
Produção USP
Search For:
Clear Search Box
Search in:
Busca Geral
Or select another collection:
Search in:
Busca Geral
Busca Avançada
Busca por Índices
This feature requires javascript
This feature requires javascript
Updates on Molecular Targeted Therapies for CNS Tumors
Pan, Edward
MDPI - Multidisciplinary Digital Publishing Institute 2023
Sem texto completo
Citações
Citado por
Serviços
Detalhes
Resenhas & Tags
Nº de Citações
This feature requires javascript
Enviar para
Adicionar ao Meu Espaço
Remover do Meu Espaço
E-mail (máximo 30 registros por vez)
Imprimir
Link permanente
Referência
EasyBib
EndNote
RefWorks
del.icio.us
Exportar RIS
Exportar BibTeX
This feature requires javascript
Título:
Updates on Molecular Targeted Therapies for CNS Tumors
Autor:
Pan, Edward
Assuntos:
A172
;
A2AAR antagonist
;
adenosine
;
adenosine receptors
;
antigen processing and presentation
;
antioxidant
;
apoptosis
;
ATRX
;
bevacizumab
;
biomarker
;
blood–brain barrier
;
Book Industry Communication
;
brain metastasis
;
brain tumor
;
cancer metabolism
;
cell cycle arrest
;
central nervous system
;
chemotherapy
;
Clinical & internal medicine
;
CNS disease
;
CNS lymphoma
;
CpG island
;
diffuse midline gliomas
;
Diseases & disorders
;
DNMT
;
EGFR
;
ependymoma
;
EPHB2
;
epidermal growth factor receptor
;
ERK/MAPK pathway
;
FGFR3
;
G-CIMP
;
GBM
;
germline mutation
;
glioblastoma
;
glioblastoma molecular classification
;
glioma
;
Group A
;
Group B
;
H3K27M
;
histone acetylation
;
IDH-mutant glioma
;
immune evasion
;
immune score
;
immunotherapy
;
intraparenchymal metastases
;
intrathecal
;
isotope labeling
;
KIF11
;
leptomeningeal
;
low grade glioma
;
LPS
;
lung cancer
;
lung carcinoma
;
lung malignancy
;
mass spectrometry
;
Medicine
;
meningitis
;
MET
;
metastatic disease
;
Metformin
;
methotrexate
;
methylation
;
methylomics
;
methyltransferases
;
MGMT
;
molecular targets
;
molecular therapy
;
monoclonal antibodies
;
MYCN
;
myxopapillary
;
n/a
;
neoantigen
;
neoplastic
;
neurofibromatosis
;
NF1
;
novel therapeutics
;
novel therapies
;
Oncology
;
patient avatars
;
PCNSL
;
PDGFRA
;
pediatric brain tumor
;
PFA
;
PFB
;
PI3K/PTEN pathway
;
plexiform neurofibroma
;
potential therapy development
;
preclinical models
;
progression
;
progression-free survival
;
radiotherapy
;
receptor tyrosine kinase
;
RELA
;
stereotactic radiosurgery
;
subependymoma
;
T cells
;
T lymphocytes
;
targeted therapy
;
temozolomide
;
tumor microenvironment
;
tumor mutation burden
;
tumor suppressor
;
tyrosine kinase inhibitors
;
U87MG
;
vestibular schwannoma
;
Warburg effect
;
whole-brain radiation therapy
;
YAP1
;
ZFTA
Descrição:
The challenges in identifying effective therapies for CNS tumors continue to be daunting. Potentially effective targeted therapies must be able to penetrate the blood–brain barrier to reach the tumor and, in sufficient concentrations, to result in meaningful treatment responses. Moreover, molecular targets must be key drivers in the growth and progression of CNS tumors. Numerous potentially efficacious therapies have failed in randomized clinical trials due to other factors, including subclonal genetic intratumoral heterogeneity (particularly within malignant gliomas), epigenetic heterogeneity, and failure to target important factors involved in the tumor microenvironment. Developing effective targeted therapies requires a thorough fundamental understanding of the genetic and epigenetic factors driving tumor progression, the interactions between CNS tumor cells and the tumor microenvironment, and the key mechanisms of tumor treatment resistance. In this Special Issue, experts in the field of CNS tumors will highlight the most promising molecular targets in the development of treatments for patients with CNS tumors.
Editor:
MDPI - Multidisciplinary Digital Publishing Institute
Data de criação/publicação:
2023
Formato:
368
Idioma:
Inglês
This feature requires javascript
This feature requires javascript
Voltar para lista de resultados
This feature requires javascript
This feature requires javascript
Buscando em bases de dados remotas. Favor aguardar.
Buscando por
em
scope:(USP_PRODUCAO),scope:(USP_EBOOKS),scope:("PRIMO"),scope:(USP),scope:(USP_EREVISTAS),scope:(USP_FISICO),primo_central_multiple_fe
Mostrar o que foi encontrado até o momento
This feature requires javascript
This feature requires javascript